Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from Analysts

Chemed Corporation (NYSE:CHE - Get Free Report) has earned a consensus rating of "Hold" from the six research firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $530.75.

Several equities research analysts recently commented on CHE shares. Oppenheimer raised their target price on Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. Zacks Research raised shares of Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. Finally, Royal Bank Of Canada raised their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th.

Insider Activity

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the firm's stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares of the company's stock, valued at $1,879,556. This trade represents a 5.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,537 shares of company stock worth $1,782,654 in the last three months. Company insiders own 3.33% of the company's stock.

Institutional Trading of Chemed

Hedge funds have recently bought and sold shares of the business. TD Asset Management Inc increased its holdings in Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock worth $138,860,000 after purchasing an additional 22,715 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company's stock worth $14,985,000 after buying an additional 4,430 shares in the last quarter. Epoch Investment Partners Inc. raised its position in Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company's stock valued at $137,945,000 after buying an additional 15,133 shares during the last quarter. Abacus FCF Advisors LLC bought a new position in Chemed during the 4th quarter valued at $5,935,000. Finally, C WorldWide Group Holding A S purchased a new position in Chemed during the 4th quarter worth $2,189,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Price Performance

Shares of NYSE CHE opened at $541.33 on Monday. The company has a market capitalization of $7.08 billion, a PE ratio of 27.19, a P/E/G ratio of 2.05 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. Chemed has a twelve month low of $365.20 and a twelve month high of $557.00. The firm has a fifty day simple moving average of $499.24 and a 200 day simple moving average of $446.50.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. During the same quarter in the prior year, the firm posted $4.27 earnings per share. The business's quarterly revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, sell-side analysts forecast that Chemed will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This is a boost from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's payout ratio is currently 14.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source